Explaining Divergent Levels of Longevity in High-Income Countries (2011) / Chapter Skim
Currently Skimming:
8 The Role of Hormone Therapy
8 The Role of Hormone Therapy
Pages 112-116
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 112... ...
. By 1995, about 40 percent of women between the ages of 50 and 74 were on HT, and the number peaked after 2000, when 92 million prescriptions were written in the United States (Hersh et al., 2004)
|
From page 113... ...
. Despite the evidence from the controlled trials, however, it appears unlikely that HT resulted in a significant increase in mortality among women in the United States.
|
From page 114... ...
. Since women in the United States begin menopause, on average, at age 51 (Manson et al., 2007)
|
From page 115... ...
Thus, it appears unlikely that HT played a role in the diverging life expectancies examined in this report. Still, for the sake of completeness, it is worthwhile to examine the second question: Was HT use significantly higher in the United States than in other countries?
|
From page 116... ...
. And while the women in some countries, such as Japan, did receive HT at a much lower rate than those in the United States, there clearly were a number of countries with both extensive HT usage and a rapid growth in female life expectancy during the crucial 1980-2005 period (Goldman, 2010b)
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.